Gastric Disease
Gastric Disease(胃病)
Gastric Disease 相关产品(92)
- GC48051Rifaximin-d6CAS: 1262992-43-7纯度: >99.00%
An internal standard for the quantification of rifaximin
- GC48128Taurocholic Acid-d4 (sodium salt)CAS: 2410279-93-3纯度: >99.00%
An internal standard for the quantification of taurocholic acid
- GC48131Taurohyodeoxycholic Acid (sodium salt)CAS: 38411-85-7纯度: >98.00%
A taurine-conjugated form of hyodeoxycholic acid
- GC48206Trimethylamine-d9 N-oxideCAS: 1161070-49-0纯度: >99.00%
An internal standard for the quantification of trimethylamine N-oxide
- GC48790Ticlopidine-d4 (hydrochloride)CAS: 2932627-17-1纯度: >99.00%
An internal standard for the quantification of ticlopidine
- GC48839Nifuroxazide-d4CAS: 1188487-83-3纯度: >99.00%
An internal standard for the quantification of nifuroxazide
- GC49062Tiopronin-d3CAS: 1189700-74-0纯度: >99.00%
An internal standard for the quantification of tiopronin
- GC492758-OxycoptisineCAS: 19716-61-1纯度: >98.00%
An isoquinoline alkaloid with anticancer and gastroprotective activities
- GC49313Picosulfate (sodium salt hydrate)CAS: 1307301-38-7纯度: >98.00%
A stimulant laxative and prodrug form of desacetyl bisacodyl
- GC49393all-trans-13,14-DihydroretinolCAS: 115797-14-3纯度: >95.00%
A metabolite of all-trans retinoic acid
- GC49401Triptolide-d3纯度: >99.00%
Triptolide-d3 (PG490-d3) 是氘标记的雷公藤内酯。雷公藤内酯是从雷公藤根中提取的二萜类三环氧化物，具有免疫抑制、抗炎、抗增殖和抗肿瘤作用。雷公藤内酯是一种 NF-κB 活化抑制剂。
- GC49663Pantoprazole sulfone N-oxideCAS: 953787-55-8纯度: >98.00%
A potential impurity found in bulk preparations of pantoprazole
- GC49692Tofacitinib-d3 (citrate)纯度: >99.00%
An internal standard for the quantification of tofacitinib
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC48044 | Resolvin E1-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48051 | Rifaximin-d6 | 1262992-43-7 | >99.00% | |
An internal standard for the quantification of rifaximin | ||||
| GC48128 | Taurocholic Acid-d4 (sodium salt) | 2410279-93-3 | >99.00% | |
An internal standard for the quantification of taurocholic acid | ||||
| GC48131 | Taurohyodeoxycholic Acid (sodium salt) | 38411-85-7 | >98.00% | |
A taurine-conjugated form of hyodeoxycholic acid | ||||
| GC48206 | Trimethylamine-d9 N-oxide | 1161070-49-0 | >99.00% | |
An internal standard for the quantification of trimethylamine N-oxide | ||||
| GC48336 | Tenapanor (hydrochloride) | 1234365-97-9 | >98.00% | |
A NHE-3 inhibitor | ||||
| GC48360 | WKYMVm (trifluoroacetate salt) | - | >98.00% | |
A synthetic peptide agonist of FPR1 and FPR2 | ||||
| GC48362 | PMX-205 (trifluoroacetate salt) | - | >95.00% | |
A potent antagonist of C5aR | ||||
| GC48374 | Saikosaponin D (hydrate) | - | >98.00% | |
A triterpene saponin with diverse biological activities | ||||
| GC48790 | Ticlopidine-d4 (hydrochloride) | 2932627-17-1 | >99.00% | |
An internal standard for the quantification of ticlopidine | ||||
| GC48839 | Nifuroxazide-d4 | 1188487-83-3 | >99.00% | |
An internal standard for the quantification of nifuroxazide | ||||
| GC48984 | Esomeprazole | 119141-88-7 | >99.00% | |
An H + /K + -ATPase inhibitor | ||||
| GC49062 | Tiopronin-d3 | 1189700-74-0 | >99.00% | |
An internal standard for the quantification of tiopronin | ||||
| GC49098 | Olsalazine-13C6 | - | >98.00% | |
An internal standard for the quantification of olsalazine | ||||
| GC49186 | O-Demethyl Apremilast | 1384441-38-6 | >95.00% | |
An active metabolite of apremilast | ||||
| GC49227 | Stachyose (hydrate) | 54261-98-2 | >95.00% | |
An oligosaccharide and prebiotic | ||||
| GC49275 | 8-Oxycoptisine | 19716-61-1 | >98.00% | |
An isoquinoline alkaloid with anticancer and gastroprotective activities | ||||
| GC49313 | Picosulfate (sodium salt hydrate) | 1307301-38-7 | >98.00% | |
A stimulant laxative and prodrug form of desacetyl bisacodyl | ||||
| GC49393 | all-trans-13,14-Dihydroretinol | 115797-14-3 | >95.00% | |
A metabolite of all-trans retinoic acid | ||||
| GC49401 | Triptolide-d3 | - | >99.00% | |
Triptolide-d3 (PG490-d3) 是氘标记的雷公藤内酯。雷公藤内酯是从雷公藤根中提取的二萜类三环氧化物，具有免疫抑制、抗炎、抗增殖和抗肿瘤作用。雷公藤内酯是一种 NF-κB 活化抑制剂。 | ||||
| GC49575 | 4-hydroxy Omeprazole sulfide | 103876-98-8 | >98.00% | |
A metabolite of omeprazole | ||||
| GC49663 | Pantoprazole sulfone N-oxide | 953787-55-8 | >98.00% | |
A potential impurity found in bulk preparations of pantoprazole | ||||
| GC49676 | 6β-hydroxy Budesonide | - | >95.00% | |
A metabolite of budesonide | ||||
| GC49692 | Tofacitinib-d3 (citrate) | - | >99.00% | |
An internal standard for the quantification of tofacitinib | ||||